Short Duration Electrical Stimulation to Improve Outcomes After Cubital Tunnel Release (SELECT) Trial

Sponsor
Epineuron Technologies Inc. (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05980767
Collaborator
Federal Economic Development Agency for Southern Ontario (FedDev Ontario) (Other)
26
2
18

Study Details

Study Description

Brief Summary

A novel temporary peripheral nerve stimulation system that delivers electrical stimulation therapy in a cubital tunnel release model will be evaluated for feasibility.

Condition or Disease Intervention/Treatment Phase
  • Device: Temporary Peripheral Nerve Stimulation System
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
26 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Short Duration Electrical Stimulation to Improve Outcomes After Cubital Tunnel Release (SELECT) Trial
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2025
Anticipated Study Completion Date :
Mar 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Experimental Intervention

Standard of care plus therapy, which consists of a single, 1 hour dose of electrical stimulation.

Device: Temporary Peripheral Nerve Stimulation System
Single use medical device. Therapy consists of single, 1 hour dose of electrical stimulation.

No Intervention: Control

Standard of care only.

Outcome Measures

Primary Outcome Measures

  1. Eligibility Rate [1.5 years]

    Evaluation of study feasibility through the number of participants who pass all pre-operative screening eligibility criteria

  2. Recruitment Rate [1.5 years]

    Evaluation of study feasibility through the number of participants who complete informed consent and are randomized into a study arm

  3. Retention Rate [1.5 years]

    Evaluation of study feasibility through the number of participants who complete all study activities

Other Outcome Measures

  1. Electromyography (EMG) Denervation Absence/Presence [1.5 years]

    Measurement of electrical activity of a muscle

  2. Nerve Conduction Study (NCS) [1.5 years]

    Measurement of speed of electrical impulse through a nerve

  3. Semmes-Weinstein Monofilament Test [1.5 years]

    Evaluation of sensory recovery through the measurement of a pressure detection threshold

  4. Static Two-Point Discrimination [1.5 years]

    Evaluation of sensory recovery through the measurement of the threshold of discrimination

  5. Grip strength [1.5 years]

    Evaluation of functional recovery through the measurement of maximum grip strength

  6. Pinch strength [1.5 years]

    Evaluation of functional recovery through the measurement of pinch strength

  7. Patient Rated Ulnar Nerve Evaluation (PRUNE) [1.5 years]

    Evaluation of pain and quality of life through patient-reported questionnaire where lower scores indicate lower pain and better quality of life related to the injury

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Ulnar neuropathy at the elbow
Exclusion Criteria:
  • Peripheral neuropathy outside of nerve of interest

  • Patients with any active implanted device

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Epineuron Technologies Inc.
  • Federal Economic Development Agency for Southern Ontario (FedDev Ontario)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Epineuron Technologies Inc.
ClinicalTrials.gov Identifier:
NCT05980767
Other Study ID Numbers:
  • EPNR-CIP-003
First Posted:
Aug 8, 2023
Last Update Posted:
Aug 8, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2023